Concepedia
Clinical Cancer Research · 2008 · 1.3K citations · 31 references
Oral curcumin is well tolerated and, despite its limited absorption, has biological activity in some patients with pancreatic cancer.
31
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations
World Health Organization, Solid Tumors, Cancer Management +17
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.8K citations
The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma
David A. Karnofsky, Walter H. Abelmann, Lloyd F. Craver et al. · Cancer · 1948 · 2.2K citations
Palliative Treatment, Medicine, Nitrogen Mustards +9
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Urinary Bladder Cancer, Chemopreventive Agent, Oncology +15